Anavex Life Sciences Corp. (LON:0HFR)
London
· Delayed Price · Currency is GBP · Price in USD 8.51
-0.29 (-3.35%)
At close: Feb 21, 2025
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of 561.87 million as of February 21, 2025. Its market cap has increased by 48.79% in one year.
Market Cap
561.87M
Enterprise Value
466.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.51
Market Cap Chart
Since April 13, 2006, Anavex Life Sciences's market cap has increased from 182.56K to 561.87M, an increase of 307,677.06%. That is a compound annual growth rate of 53.04%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.48B |
| GSK plc | 58.67B |
| Haleon | 35.36B |
| Smith & Nephew | 8.91B |
| Hikma Pharmaceuticals | 5.09B |
| ConvaTec Group | 5.01B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.24B |